25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BFRIW (Biofrontera Inc. Warrants) Stock Analysis
Buy, Hold or Sell?

Let's analyze Biofrontera Inc. Warrants together

I guess you are interested in Biofrontera Inc. Warrants. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Biofrontera Inc. Warrants’s Financial Insights
  • 📈 Technical Analysis (TA) – Biofrontera Inc. Warrants’s Price Targets

I'm going to help you getting a better view of Biofrontera Inc. Warrants. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biofrontera Inc. Warrants

I send you an email if I find something interesting about Biofrontera Inc. Warrants.

1. Quick Overview

1.1. Quick analysis of Biofrontera Inc. Warrants (30 sec.)










1.2. What can you expect buying and holding a share of Biofrontera Inc. Warrants? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$-2.24
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
$-2.24
Return On Investment
-3,443.8%

For what price can you sell your share?

Current Price per Share
$0.07
Expected price per share
$0.039 - $0.17
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biofrontera Inc. Warrants (5 min.)




Live pricePrice per Share (EOD)
$0.07
Intrinsic Value Per Share
$-105.29 - $-117.37
Total Value Per Share
$-105.29 - $-117.37

2.2. Growth of Biofrontera Inc. Warrants (5 min.)




Is Biofrontera Inc. Warrants growing?

Current yearPrevious yearGrowGrow %
How rich?$4.4m$7.4m-$3.5m-92.5%

How much money is Biofrontera Inc. Warrants making?

Current yearPrevious yearGrowGrow %
Making money-$4.4m-$5m$593k13.4%
Net Profit Margin-52.4%-73.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Biofrontera Inc. Warrants (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biofrontera Inc. Warrants?

Welcome investor! Biofrontera Inc. Warrants's management wants to use your money to grow the business. In return you get a share of Biofrontera Inc. Warrants.

First you should know what it really means to hold a share of Biofrontera Inc. Warrants. And how you can make/lose money.

Speculation

The Price per Share of Biofrontera Inc. Warrants is $0.065. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biofrontera Inc. Warrants.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biofrontera Inc. Warrants, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $-0.56 per quarter. Based on the YOY, the Book Value Change Per Share is $-3.91 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biofrontera Inc. Warrants.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-0.4%0.00-1.6%-3.96-6,085.9%-5.72-8,805.8%-5.72-8,805.8%
Usd Book Value Change Per Share0.00-0.2%-0.56-861.0%-3.91-6,018.6%0.000.1%0.000.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.2%-0.56-861.0%-3.91-6,018.6%0.000.1%0.000.1%
Usd Price Per Share0.06-0.05-0.09-0.40-0.40-
Price to Earnings Ratio-59.96--65.54-0.00--14.63--14.63-
Price-to-Total Gains Ratio-393.83--102.17--0.02--34.06--34.06-
Price to Book Ratio75.53-19.85-0.01-4.72-4.72-
Price-to-Total Gains Ratio-393.83--102.17--0.02--34.06--34.06-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.065
Number of shares15384
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.560.00
Usd Total Gains Per Share-0.560.00
Gains per Quarter (15384 shares)-8,609.260.69
Gains per Year (15384 shares)-34,437.042.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-34437-3444703-7
20-68874-6888405-4
30-103311-10332108-1
40-137748-1377580112
50-172185-1721950145
60-206622-2066320168
70-241059-24106901911
80-275496-27550602214
90-309933-30994302517
100-344370-34438002720

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%2.016.00.011.1%2.016.00.011.1%2.016.00.011.1%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%6.010.02.033.3%6.010.02.033.3%6.010.02.033.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.018.00.0%0.00.018.00.0%0.00.018.00.0%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%6.010.02.033.3%6.010.02.033.3%6.010.02.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biofrontera Inc. Warrants compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.000-0.560+362987%-3.912+2538070%0.000-445%0.000-445%
Book Value Per Share--0.0010.001+33%5.205-100%4.448-100%4.448-100%
Current Ratio--1.7221.644+5%1.347+28%1.956-12%1.956-12%
Debt To Asset Ratio--0.7990.804-1%0.8010%0.807-1%0.807-1%
Debt To Equity Ratio--3.9861.828+118%10.583-62%3.778+6%3.778+6%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--323085473.800223177674.975+45%-14892283.987+105%72391707.665+346%72391707.665+346%
Eps--0.000-0.001+312%-3.956+1563066%-5.724+2261668%-5.724+2261668%
Ev To Ebitda Ratio---12.59910.326-222%-0.197-98%3.424-468%3.424-468%
Ev To Sales Ratio--6.4355.967+8%-0.480+107%1.896+239%1.896+239%
Free Cash Flow Per Share--0.000-0.001+204%-3.993+2163886%-4.636+2512007%-4.636+2512007%
Free Cash Flow To Equity Per Share--0.0010.000+105%-2.898+527352%1.149-100%1.149-100%
Gross Profit Margin--1.0001.0000%0.982+2%1.010-1%1.010-1%
Intrinsic Value_10Y_max---117.370--------
Intrinsic Value_10Y_min---105.292--------
Intrinsic Value_1Y_max---20.198--------
Intrinsic Value_1Y_min---19.844--------
Intrinsic Value_3Y_max---54.257--------
Intrinsic Value_3Y_min---51.928--------
Intrinsic Value_5Y_max---80.564--------
Intrinsic Value_5Y_min---75.331--------
Market Cap--334841473.800236749174.975+41%124537.010+268769%56194916.221+496%56194916.221+496%
Net Profit Margin---0.111-0.524+371%-0.730+556%-0.748+573%-0.748+573%
Operating Margin---0.437-0.539+23%-0.569+30%-0.848+94%-0.848+94%
Operating Ratio--1.1371.507-25%1.752-35%1.835-38%1.835-38%
Pb Ratio80.885+7%75.53419.852+280%0.011+673438%4.724+1499%4.724+1499%
Pe Ratio-64.212-7%-59.964-65.542+9%-0.003-100%-14.629-76%-14.629-76%
Price Per Share0.065+7%0.0610.049+24%0.091-33%0.396-85%0.396-85%
Price To Free Cash Flow Ratio-88.055-7%-82.230-37.001-55%-0.007-100%-8.168-90%-8.168-90%
Price To Total Gains Ratio-421.724-7%-393.825-102.173-74%-0.018-100%-34.057-91%-34.057-91%
Quick Ratio--0.9350.757+23%0.904+3%1.282-27%1.282-27%
Return On Assets---0.063-0.201+219%-0.126+100%-0.179+184%-0.179+184%
Return On Equity---0.315-0.341+8%-1.798+471%-0.643+104%-0.643+104%
Total Gains Per Share--0.000-0.560+362987%-3.912+2538070%0.000-445%0.000-445%
Usd Book Value--4433000.0003864500.000+15%7438750.000-40%6916944.444-36%6916944.444-36%
Usd Book Value Change Per Share--0.000-0.560+362987%-3.912+2538070%0.000-445%0.000-445%
Usd Book Value Per Share--0.0010.001+33%5.205-100%4.448-100%4.448-100%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--323085473.800223177674.975+45%-14892283.987+105%72391707.665+346%72391707.665+346%
Usd Eps--0.000-0.001+312%-3.956+1563066%-5.724+2261668%-5.724+2261668%
Usd Free Cash Flow---1018000.000-2570000.000+152%-6225000.000+511%-5474333.333+438%-5474333.333+438%
Usd Free Cash Flow Per Share--0.000-0.001+204%-3.993+2163886%-4.636+2512007%-4.636+2512007%
Usd Free Cash Flow To Equity Per Share--0.0010.000+105%-2.898+527352%1.149-100%1.149-100%
Usd Market Cap--334841473.800236749174.975+41%124537.010+268769%56194916.221+496%56194916.221+496%
Usd Price Per Share0.065+7%0.0610.049+24%0.091-33%0.396-85%0.396-85%
Usd Profit---1396000.000-4439750.000+218%-5032750.000+261%-5086833.333+264%-5086833.333+264%
Usd Revenue--12551000.0009325750.000+35%8514000.000+47%7520833.333+67%7520833.333+67%
Usd Total Gains Per Share--0.000-0.560+362987%-3.912+2538070%0.000-445%0.000-445%
 EOD+3 -3MRQTTM+31 -6YOY+31 -75Y+21 -1710Y+21 -17

3.3 Fundamental Score

Let's check the fundamental score of Biofrontera Inc. Warrants based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-64.212
Price to Book Ratio (EOD)Between0-180.885
Net Profit Margin (MRQ)Greater than0-0.111
Operating Margin (MRQ)Greater than0-0.437
Quick Ratio (MRQ)Greater than10.935
Current Ratio (MRQ)Greater than11.722
Debt to Asset Ratio (MRQ)Less than10.799
Debt to Equity Ratio (MRQ)Less than13.986
Return on Equity (MRQ)Greater than0.15-0.315
Return on Assets (MRQ)Greater than0.05-0.063
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Biofrontera Inc. Warrants based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.799
Ma 20Greater thanMa 500.069
Ma 50Greater thanMa 1000.077
Ma 100Greater thanMa 2000.066
OpenGreater thanClose0.065
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Biofrontera Inc. Warrants

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Fundamental data was last updated by Penke on 2025-04-04 06:43:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biofrontera Inc. Warrants earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biofrontera Inc. Warrants to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -11.1% means that $-0.11 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biofrontera Inc. Warrants:

  • The MRQ is -11.1%. The company is making a huge loss. -2
  • The TTM is -52.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-11.1%TTM-52.4%+41.2%
TTM-52.4%YOY-73.0%+20.6%
TTM-52.4%5Y-74.8%+22.5%
5Y-74.8%10Y-74.8%0.0%
4.3.1.2. Return on Assets

Shows how efficient Biofrontera Inc. Warrants is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biofrontera Inc. Warrants to the Drug Manufacturers - Specialty & Generic industry mean.
  • -6.3% Return on Assets means that Biofrontera Inc. Warrants generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biofrontera Inc. Warrants:

  • The MRQ is -6.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -20.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.3%TTM-20.1%+13.8%
TTM-20.1%YOY-12.6%-7.5%
TTM-20.1%5Y-17.9%-2.2%
5Y-17.9%10Y-17.9%0.0%
4.3.1.3. Return on Equity

Shows how efficient Biofrontera Inc. Warrants is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biofrontera Inc. Warrants to the Drug Manufacturers - Specialty & Generic industry mean.
  • -31.5% Return on Equity means Biofrontera Inc. Warrants generated $-0.31 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biofrontera Inc. Warrants:

  • The MRQ is -31.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -34.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-31.5%TTM-34.1%+2.6%
TTM-34.1%YOY-179.8%+145.7%
TTM-34.1%5Y-64.3%+30.2%
5Y-64.3%10Y-64.3%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biofrontera Inc. Warrants.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biofrontera Inc. Warrants is operating .

  • Measures how much profit Biofrontera Inc. Warrants makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biofrontera Inc. Warrants to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -43.7% means the company generated $-0.44  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biofrontera Inc. Warrants:

  • The MRQ is -43.7%. The company is operating very inefficient. -2
  • The TTM is -53.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-43.7%TTM-53.9%+10.2%
TTM-53.9%YOY-56.9%+3.0%
TTM-53.9%5Y-84.8%+30.9%
5Y-84.8%10Y-84.8%0.0%
4.3.2.2. Operating Ratio

Measures how efficient Biofrontera Inc. Warrants is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.14 means that the operating costs are $1.14 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biofrontera Inc. Warrants:

  • The MRQ is 1.137. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.507. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.137TTM1.507-0.370
TTM1.507YOY1.752-0.245
TTM1.5075Y1.835-0.328
5Y1.83510Y1.8350.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biofrontera Inc. Warrants.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biofrontera Inc. Warrants is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.72 means the company has $1.72 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biofrontera Inc. Warrants:

  • The MRQ is 1.722. The company is able to pay all its short-term debts. +1
  • The TTM is 1.644. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.722TTM1.644+0.078
TTM1.644YOY1.347+0.298
TTM1.6445Y1.956-0.312
5Y1.95610Y1.9560.000
4.4.3.2. Quick Ratio

Measures if Biofrontera Inc. Warrants is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biofrontera Inc. Warrants to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.93 means the company can pay off $0.93 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biofrontera Inc. Warrants:

  • The MRQ is 0.935. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.757. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.935TTM0.757+0.177
TTM0.757YOY0.904-0.146
TTM0.7575Y1.282-0.525
5Y1.28210Y1.2820.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biofrontera Inc. Warrants.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biofrontera Inc. Warrants assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biofrontera Inc. Warrants to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.80 means that Biofrontera Inc. Warrants assets are financed with 79.9% credit (debt) and the remaining percentage (100% - 79.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biofrontera Inc. Warrants:

  • The MRQ is 0.799. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.804. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.799TTM0.804-0.004
TTM0.804YOY0.801+0.003
TTM0.8045Y0.807-0.003
5Y0.80710Y0.8070.000
4.5.4.2. Debt to Equity Ratio

Measures if Biofrontera Inc. Warrants is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biofrontera Inc. Warrants to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 398.6% means that company has $3.99 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biofrontera Inc. Warrants:

  • The MRQ is 3.986. The company is unable to pay all its debts with equity. -1
  • The TTM is 1.828. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ3.986TTM1.828+2.158
TTM1.828YOY10.583-8.756
TTM1.8285Y3.778-1.950
5Y3.77810Y3.7780.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biofrontera Inc. Warrants generates.

  • Above 15 is considered overpriced but always compare Biofrontera Inc. Warrants to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -59.96 means the investor is paying $-59.96 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biofrontera Inc. Warrants:

  • The EOD is -64.212. Based on the earnings, the company is expensive. -2
  • The MRQ is -59.964. Based on the earnings, the company is expensive. -2
  • The TTM is -65.542. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-64.212MRQ-59.964-4.248
MRQ-59.964TTM-65.542+5.578
TTM-65.542YOY-0.003-65.539
TTM-65.5425Y-14.629-50.913
5Y-14.62910Y-14.6290.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biofrontera Inc. Warrants:

  • The EOD is -88.055. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -82.230. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -37.001. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-88.055MRQ-82.230-5.825
MRQ-82.230TTM-37.001-45.229
TTM-37.001YOY-0.007-36.994
TTM-37.0015Y-8.168-28.832
5Y-8.16810Y-8.1680.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biofrontera Inc. Warrants is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Biofrontera Inc. Warrants:

  • The EOD is 80.885. Based on the equity, the company is expensive. -2
  • The MRQ is 75.534. Based on the equity, the company is expensive. -2
  • The TTM is 19.852. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD80.885MRQ75.534+5.351
MRQ75.534TTM19.852+55.682
TTM19.852YOY0.011+19.841
TTM19.8525Y4.724+15.128
5Y4.72410Y4.7240.000
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biofrontera Inc. Warrants.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-12-312024-03-312024-06-302024-09-302024-12-31
Depreciation and Amortization  2951230723093312-1,240-928
Interest Expense  2331,1881,421-801620-6119-4,094-4,085



5.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets22,101
Total Liabilities17,668
Total Stockholder Equity4,433
 As reported
Total Liabilities 17,668
Total Stockholder Equity+ 4,433
Total Assets = 22,101

Assets

Total Assets22,101
Total Current Assets20,700
Long-term Assets1,401
Total Current Assets
Cash And Cash Equivalents 5,905
Short-term Investments 7
Net Receivables 5,315
Inventory 6,646
Other Current Assets 2,827
Total Current Assets  (as reported)20,700
Total Current Assets  (calculated)20,700
+/-0
Long-term Assets
Property Plant Equipment 983
Intangible Assets 35
Long-term Assets Other 383
Long-term Assets  (as reported)1,401
Long-term Assets  (calculated)1,401
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities12,021
Long-term Liabilities5,647
Total Stockholder Equity4,433
Total Current Liabilities
Short-term Debt 548
Accounts payable 1,856
Other Current Liabilities 9,617
Total Current Liabilities  (as reported)12,021
Total Current Liabilities  (calculated)12,021
+/-0
Long-term Liabilities
Long term Debt 4,098
Capital Lease Obligations 824
Long-term Liabilities Other 23
Long-term Liabilities  (as reported)5,647
Long-term Liabilities  (calculated)4,945
+/- 702
Total Stockholder Equity
Common Stock9
Retained Earnings -117,409
Other Stockholders Equity 121,833
Total Stockholder Equity (as reported)4,433
Total Stockholder Equity (calculated)4,433
+/-0
Other
Capital Stock9
Cash and Short Term Investments 5,912
Common Stock Shares Outstanding 5,516,334
Liabilities and Stockholders Equity 22,101
Net Debt -983
Net Invested Capital 8,531
Net Working Capital 8,679
Property Plant and Equipment Gross 983
Short Long Term Debt Total 4,922



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
0
24,138
0
17,695
15,354
53,219
53,219
53,626
55,059
50,884
41,965
36,905
34,104
27,932
24,575
21,574
18,516
22,101
22,10118,51621,57424,57527,93234,10436,90541,96550,88455,05953,62653,21953,21915,35417,695024,1380
   > Total Current Assets 
0
19,576
0
12,730
10,137
46,421
46,421
46,981
48,493
43,140
37,223
32,296
29,611
23,075
20,155
17,471
16,931
20,700
20,70016,93117,47120,15523,07529,61132,29637,22343,14048,49346,98146,42146,42110,13712,730019,5760
       Cash And Cash Equivalents 
0
8,080
0
3,052
1,716
24,545
24,545
31,913
27,518
17,208
13,505
4,453
3,422
1,343
3,817
4,379
2,873
5,905
5,9052,8734,3793,8171,3433,4224,45313,50517,20827,51831,91324,54524,5451,7163,05208,0800
       Short-term Investments 
0
0
0
0
0
0
0
0
0
10,548
7,596
5,935
3,341
78
23
10
8
7
781023783,3415,9357,59610,548000000000
       Net Receivables 
0
3,289
0
1,783
2,046
15,689
12,431
5,046
8,082
7,406
7,866
6,194
6,506
5,162
3,691
3,504
4,874
5,315
5,3154,8743,5043,6915,1626,5066,1947,8667,4068,0825,04612,43115,6892,0461,78303,2890
       Other Current Assets 
0
498
0
488
425
1,729
4,987
487
261
810
1,586
929
274
5,584
5,719
5,632
2,650
2,827
2,8272,6505,6325,7195,5842749291,5868102614874,9871,72942548804980
   > Long-term Assets 
0
4,562
0
4,965
5,217
6,798
6,798
6,645
6,566
7,744
4,742
4,609
4,493
4,857
4,420
4,103
1,585
1,401
1,4011,5854,1034,4204,8574,4934,6094,7427,7446,5666,6456,7986,7985,2174,96504,5620
       Property Plant Equipment 
0
370
0
314
289
267
267
248
224
1,579
1,431
1,282
1,283
1,746
1,536
1,331
1,163
983
9831,1631,3311,5361,7461,2831,2821,4311,57922424826726728931403700
       Intangible Assets 
0
3,869
0
3,659
3,555
3,450
3,450
3,241
3,136
3,032
2,927
2,823
2,718
2,629
2,556
2,448
39
35
35392,4482,5562,6292,7182,8232,9273,0323,1363,2413,4503,4503,5553,65903,8690
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000
> Total Liabilities 
0
18,310
0
19,062
32,734
41,881
41,881
36,393
32,464
27,005
25,214
29,732
33,066
23,139
29,991
10,663
12,986
17,668
17,66812,98610,66329,99123,13933,06629,73225,21427,00532,46436,39341,88141,88132,73419,062018,3100
   > Total Current Liabilities 
0
4,420
0
4,031
11,291
13,836
13,836
14,876
17,143
20,894
20,450
25,352
29,124
18,088
14,036
9,268
11,032
12,021
12,02111,0329,26814,03618,08829,12425,35220,45020,89417,14314,87613,83613,83611,2914,03104,4200
       Short-term Debt 
0
0
0
0
0
0
6,694
0
0
498
484
1,595
2,252
5,286
3,045
1,698
670
548
5486701,6983,0455,2862,2521,595484498006,694000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
1,106
1,697
3,904
2,355
296
0
0
002962,3553,9041,6971,10600000000000
       Accounts payable 
0
176
0
208
367
940
658
2,221
4,459
1,278
1,799
5,900
8,622
9,006
6,661
4,578
2,027
1,856
1,8562,0274,5786,6619,0068,6225,9001,7991,2784,4592,22165894036720801760
       Other Current Liabilities 
0
4,244
0
3,823
10,924
9,654
3,242
9,413
9,442
12,176
11,135
10,736
2,417
3,796
4,330
2,992
8,335
9,617
9,6178,3352,9924,3303,7962,41710,73611,13512,1769,4429,4133,2429,65410,9243,82304,2440
   > Long-term Liabilities 
0
13,890
0
15,031
21,443
28,045
28,045
21,517
15,321
6,111
4,764
4,380
3,942
5,051
15,955
1,395
1,954
5,647
5,6471,9541,39515,9555,0513,9424,3804,7646,11115,32121,51728,04528,04521,44315,031013,8900
> Total Stockholder Equity
0
5,828
0
-1,367
-17,380
11,338
11,338
17,233
22,595
23,879
16,751
7,173
1,038
4,793
-5,416
10,911
5,530
4,433
4,4335,53010,911-5,4164,7931,0387,17316,75123,87922,59517,23311,33811,338-17,380-1,36705,8280
   Common Stock
0
8
0
8
8
17
17
19
23
27
27
27
1
2
5
5
7
9
9755212727272319171788080
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 000-3,57000000000000000
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
46,986
0
46,986
46,986
90,200
90,200
91,382
99,306
103,370
103,721
103,980
104,213
104,441
108,236
121,250
121,536
121,833
121,833121,536121,250108,236104,441104,213103,980103,721103,37099,30691,38290,20090,20046,98646,986046,9860



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue37,303
Cost of Revenue-17,855
Gross Profit19,44819,448
 
Operating Income (+$)
Gross Profit19,448
Operating Expense-36,676
Operating Income-17,210-17,228
 
Operating Expense (+$)
Research Development2,089
Selling General Administrative33,835
Selling And Marketing Expenses0
Operating Expense36,67635,924
 
Net Interest Income (+$)
Interest Income71
Interest Expense-2,106
Other Finance Cost-41
Net Interest Income-2,076
 
Pretax Income (+$)
Operating Income-17,210
Net Interest Income-2,076
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-17,737-16,683
EBIT - interestExpense = -17,737
-17,737
-15,653
Interest Expense2,106
Earnings Before Interest and Taxes (EBIT)-15,631-15,631
Earnings Before Interest and Taxes (EBITDA)-14,482
 
After tax Income (+$)
Income Before Tax-17,737
Tax Provision-22
Net Income From Continuing Ops-17,759-17,759
Net Income-17,759
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses54,531
Total Other Income/Expenses Net-5272,076
 

Technical Analysis of Biofrontera Inc. Warrants
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biofrontera Inc. Warrants. The general trend of Biofrontera Inc. Warrants is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biofrontera Inc. Warrants's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Biofrontera Inc. Warrants Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biofrontera Inc. Warrants.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.0983 < 0.158 < 0.17.

The bearish price targets are: 0.0455 > 0.0455 > 0.039.

Know someone who trades $BFRIW? Share this with them.👇

Biofrontera Inc. Warrants Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biofrontera Inc. Warrants. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biofrontera Inc. Warrants Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biofrontera Inc. Warrants. The current macd is -0.00501252.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biofrontera Inc. Warrants price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biofrontera Inc. Warrants. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biofrontera Inc. Warrants price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Biofrontera Inc. Warrants Daily Moving Average Convergence/Divergence (MACD) ChartBiofrontera Inc. Warrants Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biofrontera Inc. Warrants. The current adx is 39.79.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biofrontera Inc. Warrants shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Biofrontera Inc. Warrants Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biofrontera Inc. Warrants. The current sar is 0.17165756.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biofrontera Inc. Warrants Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biofrontera Inc. Warrants. The current rsi is 48.80. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
Biofrontera Inc. Warrants Daily Relative Strength Index (RSI) ChartBiofrontera Inc. Warrants Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biofrontera Inc. Warrants. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biofrontera Inc. Warrants price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Biofrontera Inc. Warrants Daily Stochastic Oscillator ChartBiofrontera Inc. Warrants Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biofrontera Inc. Warrants. The current cci is -21.88360391.

Biofrontera Inc. Warrants Daily Commodity Channel Index (CCI) ChartBiofrontera Inc. Warrants Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biofrontera Inc. Warrants. The current cmo is -0.85756996.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biofrontera Inc. Warrants Daily Chande Momentum Oscillator (CMO) ChartBiofrontera Inc. Warrants Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biofrontera Inc. Warrants. The current willr is -63.30798479.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biofrontera Inc. Warrants is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Biofrontera Inc. Warrants Daily Williams %R ChartBiofrontera Inc. Warrants Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biofrontera Inc. Warrants.

Biofrontera Inc. Warrants Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biofrontera Inc. Warrants. The current atr is 0.02165885.

Biofrontera Inc. Warrants Daily Average True Range (ATR) ChartBiofrontera Inc. Warrants Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biofrontera Inc. Warrants. The current obv is 936,192.

Biofrontera Inc. Warrants Daily On-Balance Volume (OBV) ChartBiofrontera Inc. Warrants Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biofrontera Inc. Warrants. The current mfi is 79.16.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Biofrontera Inc. Warrants Daily Money Flow Index (MFI) ChartBiofrontera Inc. Warrants Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biofrontera Inc. Warrants.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-21MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-31BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Biofrontera Inc. Warrants Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biofrontera Inc. Warrants based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.799
Ma 20Greater thanMa 500.069
Ma 50Greater thanMa 1000.077
Ma 100Greater thanMa 2000.066
OpenGreater thanClose0.065
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biofrontera Inc. Warrants with someone you think should read this too:
  • Are you bullish or bearish on Biofrontera Inc. Warrants? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biofrontera Inc. Warrants? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biofrontera Inc. Warrants

I send you an email if I find something interesting about Biofrontera Inc. Warrants.


Comments

How you think about this?

Leave a comment

Stay informed about Biofrontera Inc. Warrants.

Receive notifications about Biofrontera Inc. Warrants in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.